Physician profile
Ashim Wadehra
NPI 1821448721
$33,150.40
in general payments reported to CMS, 2019-2025
35 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,961 · 2020: $3,951 · 2021: $8,551 · 2022: $15K · 2023: $39.36 · 2024: $636 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $14,505.02 | 2020-2022 | |
| Paragon 28, INC. | $5,610.57 | 2019-2022 | |
| Crossroads Orthopedics, LLC | $3,074.66 | 2019-2020 | |
| Stryker Corporation | $2,513.15 | 2019-2023 | Infinity |
| Arthrex, INC. | $1,567.68 | 2022 | |
| Medline Industries LP | $1,317.46 | 2019 | |
| Vilex LLC | $1,055.12 | 2022 | |
| Osteomed LLC | $570.90 | 2019-2022 | |
| Cardiovascular Systems INC. | $464.22 | 2019-2021 | |
| Bone Support INC. | $417.22 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Integra Lifesciences Corporation | $285.58 | 2020-2022 | |
| Depuy Synthes Sales INC. | $220.84 | 2021-2022 | |
| Acumed LLC | $199.37 | 2024 | Osteomed, Acumed |
| Treace Medical Concepts, INC. | $149.97 | 2022-2024 | |
| Flower Orthopedics Coporation | $149.45 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $140.61 | 2019-2020 | |
| Nevro Corp. | $129.53 | 2021 | |
| Horizon Therapeutics Plc | $118.35 | 2022 | |
| Kuros Biosciences USA, INC | $113.29 | 2024 | Magnetos |
| Crossroads Extremity Systems, LLC | $94.44 | 2021 | |
| Smith+Nephew, INC. | $68.60 | 2022 | |
| Biotissue Holdings INC. | $67.88 | 2022 | |
| Bioventus LLC | $42.52 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $42.25 | 2021-2022 | |
| Wright Medical Technology, INC. | $31.39 | 2019 | |
| Linvatec Corporation | $29.48 | 2021 | |
| Amgen INC. | $25.27 | 2025 | Krystexxa |
| Ibsa Pharma INC. | $23.86 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.02 | 2025 | |
| Bsn Medical INC | $22.24 | 2022 | |
| Anika Therapeutics, INC. | $18.25 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.78 | 2024 | Nuzyra |
| Orthofix Medical, INC. | $14.01 | 2020 | |
| Organogenesis INC. | $13.71 | 2022 | |
| Cardinal Health 200 LLC | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashim Wadehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.